Bayer AG (BAYN):企業の財務・戦略的SWOT分析

◆英語タイトル:Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH40270FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:93
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bayer AG (BAYN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bayer AG (Bayer) discovers, develops, manufactures, and commercializes products for human health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company’s product portfolio includes prescription products, specialty pharmaceuticals, diagnostic imaging equipment, nonprescription (over-the-counter or OTC) products, seeds, crop protection solutions and non-agricultural pest control solutions. Bayer markets its healthcare and crop protection products essentially through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Mar 12,2021: March 12, 2021 Elections at the Annual Stockholders” Meeting on April 27, 2021:Bayer to further strengthen expertise and international profile of its Supervisory BoardRead more
Mar 12,2021: Bayer to further strengthen expertise and international profile of its Supervisory Board
Mar 10,2021: Bayer expects dynamic growth with higher profitability in the coming years and is accelerating its transformation
Feb 25,2021: Bayer reports steady 2020 performance despite Covid-19 pandemic
Feb 25,2021: Bayer delivers robust performance despite pandemic – foundation laid for future growth

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bayer AG – Key Facts
Bayer AG – Key Employees
Bayer AG – Key Employee Biographies
Bayer AG – Major Products and Services
Bayer AG – History
Bayer AG – Company Statement
Bayer AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Bayer AG – Business Description
Business Segment: All Other Segments
Overview
Performance
Business Segment: Consumer Health
Overview
Performance
Key Stats
Business Segment: Crop Science
Overview
Performance
Key Stats
Business Segment: Enabling Functions & Consolidation
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
Bayer AG – Corporate Strategy
Bayer AG – SWOT Analysis
SWOT Analysis – Overview
Bayer AG – Strengths
Bayer AG – Weaknesses
Bayer AG – Opportunities
Bayer AG – Threats
Bayer AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bayer AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2021: March 12, 2021 Elections at the Annual Stockholders” Meeting on April 27, 2021:Bayer to further strengthen expertise and international profile of its Supervisory BoardRead more
Mar 12, 2021: Bayer to further strengthen expertise and international profile of its Supervisory Board
Mar 10, 2021: Bayer expects dynamic growth with higher profitability in the coming years and is accelerating its transformation
Feb 25, 2021: Bayer reports steady 2020 performance despite Covid-19 pandemic
Feb 25, 2021: Bayer delivers robust performance despite pandemic – foundation laid for future growth
Feb 17, 2021: Otto Bayer Award goes to Prof. Ruth Ley PhD
Feb 17, 2021: PeptiDream announces achievement of development milestone in discovery alliance with Bayer
Feb 16, 2021: Dare Bioscience to participate at the Women’s Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021
Feb 04, 2021: National Kidney Foundation and award-winning actress Debbie Allen partner with Bayer to launch new joint initiative to educate on the increased risk of chronic kidney disease in people with Type 2 diabetes
Feb 03, 2021: Bayer announces agreement with plaintiffs’ counsel on class plan
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bayer AG, Key Facts
Bayer AG, Key Employees
Bayer AG, Key Employee Biographies
Bayer AG, Major Products and Services
Bayer AG, History
Bayer AG, Subsidiaries
Bayer AG, Joint Venture
Bayer AG, Key Competitors
Bayer AG, Ratios based on current share price
Bayer AG, Annual Ratios
Bayer AG, Annual Ratios (Cont...1)
Bayer AG, Annual Ratios (Cont...2)
Bayer AG, Interim Ratios
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bayer AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Bayer AG (BAYN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ARxIUM:医療機器:M&Aディール及び事業提携情報
    Summary ARxIUM, formerly Intelligent Hospital Systems Inc, a subsidiary of Van Humbeck Family, is a medical device company that designs and manufactures automated solutions for the hospital pharmacy. The company’s products include RxWorks pro, workflow, inventory management, IV compounding system, h …
  • Royal KPN N.V.:企業のM&A・事業提携・投資動向
    Royal KPN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal KPN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Breko GmbH:企業の戦略・SWOT・財務情報
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ICON Health & Fitness, Inc.:企業の戦略・SWOT・財務情報
    ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Stemgent Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stemgent Inc (Stemgent), a part of the ReproCELL Group is a biotechnology company that focuses on the development of innovative technology and application solutions for the advancement of stem cell research. The company’s product portfolio comprises antibodies, cell lines, cytokines / protei …
  • Medtecs International Corp Ltd (546):企業の財務・戦略的SWOT分析
    Summary Medtecs International Corporation Ltd (Medtecs) is a medical device company that manufactures and distributes work wear apparels and medical device and consumables. The company's products include medical devices, healthcare textile work wear and hospitality textiles, among others. It also pr …
  • Ilyushin Aviation Complex OJSC:企業の戦略・SWOT・財務情報
    Ilyushin Aviation Complex OJSC - Strategy, SWOT and Corporate Finance Report Summary Ilyushin Aviation Complex OJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • KineMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …
  • Tutunski Kombinat AD Prilep:企業の戦略・SWOT・財務分析
    Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report Summary Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …
  • Biafo Industries Ltd (BIFO):企業の財務・戦略的SWOT分析
    Biafo Industries Ltd (BIFO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Jubilee General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Shinsei Bank Ltd:企業のM&A・事業提携・投資動向
    Shinsei Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinsei Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Chemed Corp (CHE):企業の財務・戦略的SWOT分析
    Summary Chemed Corp (Chemed) is a diversified company. The company operates through its segments including Vitas and Roto-Rooter. Its Vitas segment provides end-of-life hospice care for heart disease, stroke, multiple sclerosis, lung disease, liver disease, and kidney diseases, among others. Chemed …
  • Engepack Embalagens Sa:企業の戦略・SWOT・財務分析
    Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • Beiersdorf AG (BEI):企業の財務・戦略的SWOT分析
    Beiersdorf AG (BEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Reply SpA (REY):企業の財務・戦略的SWOT分析
    Reply SpA (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆